[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Invest in Autonomix today.

WINK Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 67.54%

Insider Buying (Last 12 Months): £26,755

Insider Selling (Last 12 Months): GBX 0

M Winkworth Insider Trading History Chart

M Winkworth Share Price & Price History

GBX 150

▲ +2.5 (1.69%)

As of 11/29/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Invest in Autonomix today.

M Winkworth Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/23/2023	Simon Agace	Insider	Buy	3,500	GBX 1	GBX 3,500
6/8/2023	Dominic Agace	Insider	Buy	16,700	GBX 160	£26,720
7/1/2022	Simon Agace	Insider	Buy	900	GBX 162	£1,458

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for M Winkworth (LON:WINK)

26.65% of M Winkworth stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

M Winkworth PLC operates as a franchisor to the Winkworth estate agencies in the United Kingdom. It provides estate agency sales franchising, residential lettings, and letting and property management services under the Winkworth brand. The company was founded in 1835 and is based in London, the United Kingdom.

Read More

Today's Range

Now: GBX 150

141.05

153.50

50 Day Range

MA: GBX 143.69

135

152.25

52 Week Range

Now: GBX 150

110

190

Volume

8,136 shs

Average Volume

3,825 shs

Market Capitalization

£19.37 million

P/E Ratio

1,153.85

Dividend Yield

7.73%

Beta

0.83

Who are the company insiders with the largest holdings of M Winkworth?: M Winkworth's top insider shareholders include:
Dominic Agace (Insider)
Simon Agace (Insider)
Learn More about top insider investors at M Winkworth.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Invest in Autonomix today.